Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
82 HP 175 IGF-1 LR3 Long R3 IGF-1 extended half-life anabolic research compound ALIASES Long R3 IGF-1, LR3 IGF-1, IGF-1LR3, IGF1 LR3 CLASS Synthetic 83-residue insulin-like growth factor 1 analog FORMULA C400H625N111O115S9 HALF-LIFE ~6 hours (vs ~10 minutes native IGF-1) ROUTES Subcutaneous (research) MECHANISM OF ACTION Long R3 Insulin-like Growth Factor 1 83-residue synthetic analog of native IGF-1 with N-terminal 13-residue extension and Arg substitution at position 3
"The Heavy Price of GLP-1 Drugs: How Financialization Drives Pharmaceutical Patent Abuse and Health Inequities." 2025
1L advanced NSCLCclinical BNT113BNT113 / HPV16 / mRNA cancer immunotherapy / Oncology1L HPV16+ HNSCCclinical GotistobartCTLA-4 / immunomodulator / OncologyMetastatic NSCLC
Peptides are classified as research compounds in most jurisdictions and are not approved by the FDA for human use
As part of the incretin hormone family, GLP-1 helps coordinate the body's response to eating (NIH)
For example, inhibition of HMGB1 may not only impede wound healing and compromise tissue regeneration but also disrupt immune-mediated pathogen clearance, thereby augmenting susceptibility to infections [443]
US$ 26.16
US$ 20.87
US$ 24.41
US$ 26.10
US$ 28.01
US$ 26.26
US$ 28.84
US$ 24.71
US$ 25.52
